Baldwin Requests Funding to Study Opioid Crisis
Sen. Tammy Baldwin is behind a push for better data collection and monitoring of opioid use
As the crisis of the COVID-19 pandemic plays out across the country, so, too, does the crisis of opioid addiction and overdose death. The spread of COVID-19 hasn’t eliminated addiction, but it has altered treatment access, and added the mental pressures of social isolation. That’s why a group of U.S. senators are requesting more funding for data collection and better monitoring of the opioid crisis as it continues during the pandemic.
U.S. Senators Tammy Baldwin (D-WI), Jeanne Shaheen (D-NH) are spearheading the effort, backed by 17 of their Senate colleagues. In a joint letter to the leaders of both parties in Congress, the group noted that the COVID-19 pandemic has “dramatically altered the substance use disorder prevention, treatment, and recovery landscape in this country.” Nevertheless, it continues, “the needs of patients and communities are clear.”
Due to the various business shutdowns and the sudden implementation of social distancing many treatment centers either closed or altered their admission process. For patients, the idea of not being able to get help when you need it is jarring. Some have only recently considered recovery, while others are on medication-assisted treatment programs with tight needs and schedules. Not all treatment facilities have closed their doors, however, and instead have worked hard to keep up with what appears to be a growing demand for recovery.
On April 4, the Milwaukee County Medical Examiner’s Office tweeted that overdoses “continue to surge” from its own area. “If current trends continue, 640 people will die in Milwaukee County this year from a drug overdose.” Spikes in overdoses can be caused by a so-called “bad batch” of narcotics laced with a more lethal substance, like a fentanyl analog. The pandemic, however, has created a unique breeding environment for isolation, depression, and economic desperation.
“Congress must continue to rise to this challenge,” the senators urged, “now exacerbated by the COVID-19 pandemic.” They are calling for increased funding to support targeted responses to the addiction crisis in communities. “To this end,” reads the letter, “we urge you to provide $2 billion in funding for the Substance Abuse and Mental Health Services Administration (SAMHSA) to administer supplemental grant allocations under the Substance Abuse Prevention and Treatment (SAPT) Block Grant program and the state opioid response grant program.”
According to the Department of Health Services (DHS), by the end of 2019, Wisconsin saw over 3,700 opioid-related inpatient and emergency room hospital visits. “As we look to the future,” the senators state in their letter, “it is critical that the needs of providers are met in order to respond to the needs of those struggling with substance misuse, as well as the impacts of the COVID-19 pandemic.”
Reprinted with permission of Wisconsin Examiner.
- A Medication Rescue for Opioid Overdoses - Corri Hess - Feb 22nd, 2021
- State Receives $10 million in Opioid Crisis Settlement - Jenny Peek - Feb 5th, 2021
- AG Kaul, Gov Evers Announce $573 Million Multistate Agreement with McKinsey & Company for “Turbocharging” the Opioid Epidemic with Purdue Pharma - Josh Kaul - Feb 4th, 2021
- Gov. Evers, DHS Announce Nearly $9 Million Awarded for Drug Treatment Services - Gov. Tony Evers - Jan 14th, 2021
- AG Kaul, Bipartisan AGs Push FDA to Examine Progress in Opioid Fight - Josh Kaul - Jan 11th, 2021
- Milwaukee County Surpasses Last Year’s Record Overdose Deaths - Edgar Mendez - Nov 27th, 2020
- Overdose Responders Struggle Against Rising Deaths - Edgar Mendez - Nov 20th, 2020
- Wisconsin Drug Take Back Collection 1st in the Country; Collects Nearly 90,000 lbs. of Unwanted Medications to Fight the Opioid Epidemic - Josh Kaul - Nov 9th, 2020
- Gov. Evers, DSPS Secretary-designee Crim Announce Wisconsin Enhanced Prescription Drug Monitoring Program Awarded Nearly $2 Million Grant - Gov. Tony Evers - Nov 2nd, 2020
- AG Kaul Announces Updated Settlement with Opioid Manufacturer Mallinckrodt - Josh Kaul - Oct 13th, 2020
Read more about Opioid Crisis here